PXL proteome systems limited

new deal on prostrate cancer test - $1.5b market

  1. ds
    7,131 Posts.
    clock Created with Sketch.
    07/03/06
    10:41
    Post #: 1415911
    NICE announcement about a prostrate cancer test - 100% accurate on the test group and only 17% of false positives compared to the current avaliable test which gives 75% of false positives. Estimated $1.5b test market. First stage fully funded by Egenix.
    PXL Price at posting: 0.0¢ Sentiment: None Disclosure: Not Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Win a $12k Portfolio | 7%-10.25% low risk rental yield from a proven asset
right-arrow Created with Sketch.
NEWS Iress Ltd leads top gainers intraday Friday as Blackstone buyout bid confirmed
right-arrow Created with Sketch.
NEWS Lithium hype is back. Just ignore the fact Jianxiawo only supplies 3% globally
right-arrow Created with Sketch.
NEWS The 10 hot stocks HotCopper users watchlisted in Week 32
right-arrow Created with Sketch.
NEWS What the hell is wrong with ASX Ltd? The hits keep coming, and now CBOE looms
right-arrow Created with Sketch.
NEWS Expert Exchange: Laretive's 4 key strategies to picking ASX winners
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.